Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAN-DRE: Cannabinoids for Drug Resistant Epilepsy
NCT07023744Phase 2Not yet recruiting
- Sponsor
- University of Manitoba
- Start
- Jul 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cannabidiol in epilepsy, sponsored by University of Manitoba. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07023744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023744.